About Ri18 Labs
A considered approach to research supply.
Ri18 Labs is a U.S.-based supplier of research peptides. We exist to make them easier to trust — clearly identified, labeled to the lot, and documented in a way a researcher can read and check.
(01)Why we exist
Research depends on knowing exactly what is in the vial. Too often, that knowledge is assumed rather than documented.
We are building Ri18 Labs around documentation rather than description. Every listing states the material's full chemical identity. Every unit belongs to a lot. Every certificate belongs to one lot and can be retrieved by anyone holding that lot number.
We would rather offer fewer peptides, documented properly, than many described loosely. Where a procedure is still being put in place, we say so — on the page, next to the claim.
(02)Our approach
Where thoughtful science meets exceptional standards.
Ri18 Labs is a U.S.-based supplier of research peptides, built on the idea that a vial is only as useful as what can be proven about its contents.
We focus on three things: knowing exactly what is in each vial, tracing every vial to the lot it came from, and supplying it responsibly to the laboratories and research organizations that need it. Documentation comes first; everything else follows.
01
Identity
Each peptide is named by its full identity — sequence, CAS number where assigned, formula and weight — never by a nickname.
02
Traceability
Every vial carries its lot number, and every lot is meant to carry its own documentation, retrievable online.
03
Responsibility
Supplied for qualified laboratory research only — with no therapeutic claims and no human-use guidance.
(03)Quality
Confidence Built on Documentation.
Trust in a research material should rest on evidence you can read, not on adjectives. Our standards define what must be documented for a lot before it can be released.
Ri18 Labs is preparing for launch. Each standard is labeled with its current status, and we update those labels only when a procedure is actually in operation.
Every peptide is described by its full chemical name, its amino-acid sequence, its CAS number where one is assigned, and its molecular formula and weight — never by a nickname or an abbreviation that obscures what it is.
- Identity fields, including sequence, are recorded for each peptide and checked against source documentation before publication.
- Names on vial labels, listings and certificates must match exactly.
- Identity is confirmed analytically for each lot, as part of independent testing.
(04)The label
Every vial, labeled to be checked.
A label should answer the questions a researcher asks before opening a vial: what it is, which lot it came from, and where the evidence for it lives.
Identity
The peptide’s full name, exactly as it appears on its certificate — never a nickname or code.
Lot number
Printed on every vial. Enter it online to retrieve the certificate issued for that lot.
Quantity & form
Fill quantity and physical form, as documented for the lot.
Storage
Conditions from the lot’s Safety Data Sheet, supplied with every order.
Research-use statement
For laboratory research use only. Not for human or veterinary use.
(05)What we commit to
- 01Name every peptide by its full identity, including its sequence.
- 02Print the lot on every vial, and bind every certificate to exactly one lot.
- 03Publish analytical results exactly as the laboratory reports them.
- 04Say plainly which procedures are in place and which are still planned.
- 05Supply for laboratory research only, with a research-use declaration on every order.
(06)What we will not do
- Make health, wellness, weight, performance or recovery claims.
- Provide dosing, preparation-for-use or human-use guidance of any kind.
- Use euphemistic or abbreviated names that obscure what a material is.
- Treat a “research use only” label as permission to sell anything.
- Publish a certificate, result or credential that we cannot substantiate.
Where we are today
Preparing to open, carefully.
Ri18 Labs is in its pre-launch phase. Our catalog will open peptide by peptide, each one only after its regulatory review, documentation and supply arrangements are complete.
Correspondence
Announcements & research-supply updates
Occasional, considered notes on catalog availability, documentation and company news. Sent only with your consent.